Rita Hwang1, Jared Bruning, Norman Morris, Allison Mandrusiak, Trevor Russell. 1. Department of Physiotherapy, Princess Alexandra Hospital, Metro South Health, Brisbane, Queensland, Australia (Ms Hwang); Department of Physiotherapy, Heart Failure Support Service, The Prince Charles Hospital, Brisbane, Queensland, Australia (Mr Bruning); The Menzies Health Institute Queensland and The School of Allied Health Sciences, Griffith University, Gold Coast, Queensland, Australia (Dr Morris); and Physiotherapy, School of Health & Rehabilitation Sciences, The University of Queensland, Brisbane, Queensland, Australia (Drs Mandrusiak and Russell and Ms Hwang).
Abstract
PURPOSE: To examine the effects of telerehabilitation compared with other delivery models for improving physical or functional outcomes in patients with cardiopulmonary diseases. METHODS: A search was completed for English language publications from 1990 to August 2013 across 4 electronic databases and gray literature. Inclusion criteria were: (1) home-based telerehabilitation as a core component; (2) at least 2 exercise sessions; (3) randomized controlled trials; and (4) reporting of physical or functional outcome measures in adult patients with coronary heart disease, chronic heart failure, and chronic respiratory disease. Studies were independently screened by 2 reviewers and graded by a reviewer according to the Downs and Black checklist. A narrative synthesis of the included studies was undertaken. RESULTS: Eleven studies were analyzed. It appears that telerehabilitation is no different to other delivery models for patients with cardiopulmonary diseases, in terms of exercise capacity expressed as distance on the 6-minute walk test and peak oxygen consumption and quality of life. Telerehabilitation appears to have higher adherence rates compared with center-based exercise. There has been similar or no adverse events reported in telerehabilitation compared with center-based exercise. CONCLUSIONS: Although telerehabilitation shows promise in patients with cardiopulmonary diseases, compelling evidence is still limited. There is a need for more detailed, high-quality studies and for studies on the use of video-based telerehabilitation.
PURPOSE: To examine the effects of telerehabilitation compared with other delivery models for improving physical or functional outcomes in patients with cardiopulmonary diseases. METHODS: A search was completed for English language publications from 1990 to August 2013 across 4 electronic databases and gray literature. Inclusion criteria were: (1) home-based telerehabilitation as a core component; (2) at least 2 exercise sessions; (3) randomized controlled trials; and (4) reporting of physical or functional outcome measures in adult patients with coronary heart disease, chronic heart failure, and chronic respiratory disease. Studies were independently screened by 2 reviewers and graded by a reviewer according to the Downs and Black checklist. A narrative synthesis of the included studies was undertaken. RESULTS: Eleven studies were analyzed. It appears that telerehabilitation is no different to other delivery models for patients with cardiopulmonary diseases, in terms of exercise capacity expressed as distance on the 6-minute walk test and peak oxygen consumption and quality of life. Telerehabilitation appears to have higher adherence rates compared with center-based exercise. There has been similar or no adverse events reported in telerehabilitation compared with center-based exercise. CONCLUSIONS: Although telerehabilitation shows promise in patients with cardiopulmonary diseases, compelling evidence is still limited. There is a need for more detailed, high-quality studies and for studies on the use of video-based telerehabilitation.
Authors: Krzysztof Milewski; Andrzej Małecki; Dominika Orszulik-Baron; Mateusz Kachel; Piotr Hirnle; Marek Orczyk; Rafał Dunal; Grzegorz Mikołajowski; Adam Janas; Zbigniew Nowak; Karol Kozak; Wojciech Roskiewicz; Katarzyna Nierwińska; Andrzej Izworski; Adam Rybicki; Piotr P Buszman; Ryszard Piotrowicz; Pawel E Buszman Journal: Cardiol J Date: 2018-12-19 Impact factor: 2.737
Authors: Narelle S Cox; Simone Dal Corso; Henrik Hansen; Christine F McDonald; Catherine J Hill; Paolo Zanaboni; Jennifer A Alison; Paul O'Halloran; Heather Macdonald; Anne E Holland Journal: Cochrane Database Syst Rev Date: 2021-01-29
Authors: Lindsey Anderson; Georgina A Sharp; Rebecca J Norton; Hasnain Dalal; Sarah G Dean; Kate Jolly; Aynsley Cowie; Anna Zawada; Rod S Taylor Journal: Cochrane Database Syst Rev Date: 2017-06-30
Authors: Rutger W M Brouwers; Jos J Kraal; Simone C J Traa; Ruud F Spee; Laurence M L C Oostveen; Hareld M C Kemps Journal: BMC Cardiovasc Disord Date: 2017-01-31 Impact factor: 2.298
Authors: Emily R Ramage; Natalie A Fini; Elizabeth A Lynch; Amanda Patterson; Catherine M Said; Coralie English Journal: BMJ Open Date: 2019-03-20 Impact factor: 2.692
Authors: Andrea Avila; Jomme Claes; Kaatje Goetschalckx; Roselien Buys; May Azzawi; Luc Vanhees; Véronique Cornelissen Journal: J Med Internet Res Date: 2018-06-22 Impact factor: 5.428